Angel A, D'Costa M A, Yuen R
Can J Biochem. 1979 Jun;57(6):578-87. doi: 10.1139/o79-073.
Human adipose tissue derives its cholesterol primarily from circulating lipoproteins. To study fat cell-lipoprotein interactions, low density lipoprotein (LDL) uptake and metabolism were examined using isolated human adipocytes. The 125I-labelled LDL (d = 1.025-1.045) was bound and incorporated by human fat cells in a dose-dependent manner with an apparent Km of 6.9 + 0.9 microgram LDL protein/mL and a Vmax of 15-80 microgram LDL protein/mg lipid per 2 h. In time-course studies, LDL uptake was characterized by rapid initial binding followed by a linear accumulation for at least 4 h. The 125I-labelled LDL degradation products (trichloroacetic acid soluble iodopeptides) accumulated in the incubation medium in a progressive manner with time. Azide and F- inhibited LDL internalization and degradation, suggesting that these processes are energy dependent. Binding and cellular internalization of 125I-labelled LDL lacked lipoprotein class specificity in that excess (25-fold) unlabelled very low density lipoprotein (VLDL) (d less than 1.006) and high density lipoprotein (HDL) (d = 1.075-1.21) inhibited binding and internalization of 125I-labelled LDL. On an equivalent protein basis HDL was the most potent. The 125I-labelled LDL binding to an adipocyte plasma membrane preparation was a saturable process and almost completely abolished by a three- to four-fold greater concentration of HDL. The binding, internalization, and degradation of LDL by human adipocytes resembled that reported by other mesenchymal cells and could account for a significant proportion of in vivo LDL catabolism. It is further suggested that adipose tissue is an important site of LDL and HDL interactions.
人体脂肪组织的胆固醇主要来源于循环脂蛋白。为了研究脂肪细胞与脂蛋白的相互作用,利用分离出的人体脂肪细胞对低密度脂蛋白(LDL)的摄取和代谢进行了检测。125I标记的LDL(d = 1.025 - 1.045)以剂量依赖方式被人体脂肪细胞结合并摄取,其表观米氏常数为6.9 ± 0.9微克LDL蛋白/毫升,最大反应速度为每2小时15 - 80微克LDL蛋白/毫克脂质。在时间进程研究中,LDL摄取的特点是最初快速结合,随后至少4小时呈线性积累。125I标记的LDL降解产物(三氯乙酸可溶性碘肽)在孵育培养基中随时间逐渐积累。叠氮化物和氟化物抑制LDL的内化和降解,表明这些过程依赖能量。125I标记的LDL的结合和细胞内化缺乏脂蛋白类别特异性,因为过量(25倍)未标记的极低密度脂蛋白(VLDL)(d < 1.006)和高密度脂蛋白(HDL)(d = 1.075 - 1.21)抑制125I标记的LDL的结合和内化。在等量蛋白基础上,HDL的作用最显著。125I标记的LDL与脂肪细胞质膜制剂的结合是一个可饱和过程,HDL浓度增加三到四倍几乎可完全消除该结合。人体脂肪细胞对LDL的结合、内化和降解与其他间充质细胞的情况相似,可能占体内LDL分解代谢的很大比例。进一步表明脂肪组织是LDL与HDL相互作用的重要场所。